STOCKHOLDERS EQUITY (DEFICIT) |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| STOCKHOLDERS EQUITY (DEFICIT) | |
| STOCKHOLDERS' EQUITY (DEFICIT) | NOTE 10 – STOCKHOLDERS’ EQUITY (DEFICIT)
Reverse Recapitalization Impact on Equity
On August 2, 2026, the Company completed a reverse recapitalization transaction with Light Across, which resulted in a recapitalization of the Company’s equity structure. As part of the transaction, the historical equity of Light Across was retroactively adjusted to reflect the legal capital structure of the Company.
Accordingly, all share and per-share amounts presented in the accompanying Condensed Consolidated Financial Statements have been retroactively adjusted to reflect this transaction.
Preferred Stock
Preferred Stock Series A
As of December 31, 2025, the Company has authorized 50,000,000 shares of preferred stock Series A, with a par value of $0.001 per share. As of August 28, 2026, the Board of Directors approved the number of shares of common stock authorized for issuance increased from 7,450,000,000 to 9,950,000,000.
As of September 30, 2026 and December 31, 2025, the Company had 3,189,600 and nil shares of preferred stock Series A issued and outstanding, respectively.
Preferred Stock Series B
As of August 11, 2026, the Company has authorized 1 preferred stock Series B and issued it to Mr. Ximing Huang, the Company’s Chairman of the Board of Directors and Chief Executive Officer at the same date.
As of September 30, 2026 and December 31, 2025, the Company had 1 and nil share of preferred stock Series B issued and outstanding, respectively.
Common Stock
The Company has 7,450,000,000 shares of common stock authorized for issuance pursuant to its articles of incorporation.
As of August 22, 2026, the Board approved an amendment to the articles of incorporation to increase the number of shares of common stock authorized for issuance from 7,450,000,000 to 9,950,000,000.
In the second quarter of 2026, the Company converted an aggregate of $20,000 outstanding principal of the 1180 Note into 27,972,028 shares of its common stock.
In the third quarter of 2026, the Company converted an aggregate of $58,146 outstanding principal of the 1180 Note into 203,188,034 shares of its common stock.
As of September 30, 2026 and December 31, 2025, the Company had 6,451,736,079 and 4,998,838,436 shares of common stock issued and outstanding, respectively. |